Cargando…
The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model
Late 2020, SARS-CoV-2 Alpha variant emerged in United Kingdom and gradually replaced G614 strains initially involved in the global spread of the pandemic. In this study, we use a Syrian hamster model to compare a clinical strain of Alpha variant with an ancestral G614 strain. The Alpha variant succe...
Autores principales: | Cochin, Maxime, Luciani, Léa, Touret, Franck, Driouich, Jean-Sélim, Petit, Paul-Rémi, Moureau, Grégory, Baronti, Cécile, Laprie, Caroline, Thirion, Laurence, Maes, Piet, Boudewijns, Robbert, Neyts, Johan, de Lamballerie, Xavier, Nougairède, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913834/ https://www.ncbi.nlm.nih.gov/pubmed/35273335 http://dx.doi.org/10.1038/s42003-022-03171-9 |
Ejemplares similares
-
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model
por: Cochin, Maxime, et al.
Publicado: (2022) -
Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021) -
Replicative Fitness of a SARS-CoV-2 20I/501Y.V1 Variant from Lineage B.1.1.7 in Human Reconstituted Bronchial Epithelium
por: Touret, Franck, et al.
Publicado: (2021) -
Activity of Sotrovimab against BQ.1.1 and XBB.1 Omicron sublineages in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2023) -
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
por: Touret, Franck, et al.
Publicado: (2021)